These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11850381)

  • 1. Monitoring safety of over the counter drugs. Patients could do more than just treat themselves.
    Wade AG
    BMJ; 2002 Feb; 324(7334):424-5. PubMed ID: 11850381
    [No Abstract]   [Full Text] [Related]  

  • 2. Monitoring safety of over the counter drugs. Over the counter medicines must be treated like all other medicines.
    Walmsley J; Marshall G
    BMJ; 2002 Feb; 324(7334):424-5. PubMed ID: 11855392
    [No Abstract]   [Full Text] [Related]  

  • 3. Monitoring the safety of over the counter drugs.
    Henry DA; McEwen J
    Br Med J (Clin Res Ed); 1987 Nov; 295(6610):1414. PubMed ID: 3121035
    [No Abstract]   [Full Text] [Related]  

  • 4. Over-the-counter product line extensions: have we reached the limit yet?
    Sansgiry SS
    J Am Geriatr Soc; 2004 Jul; 52(7):1223-4. PubMed ID: 15209675
    [No Abstract]   [Full Text] [Related]  

  • 5. Are H2 receptor antagonists safe over the counter drugs?
    Andersen M; Schou JS
    BMJ; 1994 Aug 20-27; 309(6953):493-4. PubMed ID: 8086898
    [No Abstract]   [Full Text] [Related]  

  • 6. Monitoring the safety of over the counter drugs.
    Volans GN
    Br Med J (Clin Res Ed); 1987 Oct; 295(6602):797-8. PubMed ID: 3119043
    [No Abstract]   [Full Text] [Related]  

  • 7. The safety of over-the-counter drugs: some reflections and unanswered questions.
    Shader RI; Greenblatt DJ
    J Clin Psychopharmacol; 2003 Apr; 23(2):111-2. PubMed ID: 12640210
    [No Abstract]   [Full Text] [Related]  

  • 8. Monitoring the safety of over the counter drugs. We need a better way than spontaneous reports.
    Clark D; Layton D; Shakir SA
    BMJ; 2001 Sep; 323(7315):706-7. PubMed ID: 11576964
    [No Abstract]   [Full Text] [Related]  

  • 9. OTC survival guide. FAQs on OTCs. Here are answers to your questions about over-the-counter remedies.
    Quartetti HR
    Diabetes Forecast; 2004 Feb; 57(2):68-71. PubMed ID: 14976939
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacovigilance of over-the-counter products based in community pharmacy: methodological issues from pilot work conducted in Hampshire and Grampian, UK.
    Layton D; Sinclair HK; Bond CM; Hannaford PC; Shakir SA
    Pharmacoepidemiol Drug Saf; 2002 Sep; 11(6):503-13. PubMed ID: 12426936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bad medicine. Monitoring programs target substandard drugs.
    Grens K
    Mod Healthc; 2013 May; 43(20):30-1. PubMed ID: 23947275
    [No Abstract]   [Full Text] [Related]  

  • 12. Monitoring medicines: opportunity knocks.
    Snell E
    Br Med J (Clin Res Ed); 1987 Nov; 295(6607):1209. PubMed ID: 3120947
    [No Abstract]   [Full Text] [Related]  

  • 13. Surveillance and safety.
    Eriksson LI; Leander E; Lennmarken C
    Br J Anaesth; 1990 Oct; 65(4):594-5. PubMed ID: 2248831
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety and tooth whiteners.
    Le VP
    J Can Dent Assoc; 1991 Dec; 57(12):925-6. PubMed ID: 1760777
    [No Abstract]   [Full Text] [Related]  

  • 15. [Explore method about post-marketing safety re-evaluation of Chinese patent medicines based on HIS database in real world].
    Yang W; Xie Y; Zhuang Y
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2779-82. PubMed ID: 22292363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The FDA and safety--beyond the heparin crisis.
    Laurencin CT; Nair L
    Nat Biotechnol; 2008 Jun; 26(6):621-3. PubMed ID: 18536680
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of automated record linkage in the postmarketing surveillance of drug safety: a critique.
    Shapiro S
    Clin Pharmacol Ther; 1989 Oct; 46(4):371-86. PubMed ID: 2535647
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment of undesirable events in cosmetic market surveillance: background, description and use of a causality assessment method in cosmetovigilance.
    Bons B; Audebert F; Bitaudeau C; Cachin N; Colson L; Farr C; Fix LA; Gilmour N; Gorni R; Griffiths M; Harris B; Holle V; Kirk S; Meredith E; Pari C; Poinsot P; Renner G;
    Regul Toxicol Pharmacol; 2010 Dec; 58(3):349-53. PubMed ID: 20619309
    [No Abstract]   [Full Text] [Related]  

  • 19. OTC survival guide. 20 questions. Do you how to safely get the greatest benefit from over-the-counter (OTC) drugs and products? Answer these 20 questions and find out!
    Roberts SS
    Diabetes Forecast; 2004 Feb; 57(2):57-8, 60-1. PubMed ID: 14976937
    [No Abstract]   [Full Text] [Related]  

  • 20. [Analysis on correlation between sales of over-the-counter drugs and the incidence of influenza-like-illness].
    Guo JH; Zhou JK; Feng SQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Mar; 29(3):307-8. PubMed ID: 18788537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.